Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Payam Tabarsi and Seyed Hashemian.
Payam Tabarsi
Connection Strength
0.630
Seyed Hashemian
  1. IgM-enriched immunoglobulin in COVID-19: Case series of 15 severely ill SARS-CoV-2-infected patients. Int Immunopharmacol. 2021 Oct; 99:107998.
    View in: PubMed
    Score: 0.239
  2. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. Int Immunopharmacol. 2020 Nov; 88:106869.
    View in: PubMed
    Score: 0.224
  3. Clinical Features and Outcomes of ICU Patients with COVID-19 Infection in Tehran, Iran: a Single-Centered Retrospective Cohort Study. Tanaffos. 2020 Dec; 19(4):300-311.
    View in: PubMed
    Score: 0.057
  4. Reply to: Psychophysical olfactory testing in COVID-19: is smell function really impaired in nearly all patients? Int Forum Allergy Rhinol. 2020 08; 10(8):953-954.
    View in: PubMed
    Score: 0.056
  5. Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces. Iran J Pharm Res. 2020; 19(1):1-2.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.